Allergan Is a $63 Billion Botox Job for AbbVie

(Bloomberg Opinion) -- When the maker of the top-selling arthritis drug says it’s buying a leader in anti-wrinkle treatments, you’d be forgiven if your initial response to the news was that it seem...

Bloomberg Quint

Add BloombergQuint App to Home screen.